Hot-melt extrusion: from theory to application in pharmaceutical formulation—where are we now?

H Patil, SK Vemula, S Narala, P Lakkala… - AAPS …, 2024 - Springer
Hot-melt extrusion (HME) is a globally recognized, robust, effective technology that
enhances the bioavailability of poorly soluble active pharmaceutical ingredients and offers …

Amorphous solid dispersions: Stability mechanism, design strategy and key production technique of hot melt extrusion

J Han, M Tang, Y Yang, W Sun, Z Yue, Y Zhang… - International Journal of …, 2023 - Elsevier
Solid dispersion (SD) system has been used as an effective formulation strategy to increase
in vitro and in vivo performances of poorly water-soluble drugs, such as …

Strategies to improve the stability of amorphous solid dispersions in view of the hot melt extrusion (HME) method

ALJ Khater, SH Almurisi, S Mahmood… - International Journal of …, 2023 - Elsevier
Oral administration of drugs is preferred over other routes for several reasons: it is non-
invasive, easy to administer, and easy to store. However, drug formulation for oral …

Quantification of Soluplus® and copovidone polymers in dissolution media: Critical systematic review

ZM Horváth, L Lauberte, K Logviss, D Bandere… - Journal of Drug Delivery …, 2023 - Elsevier
Polymer-based solid dispersions including amorphous solid dispersions (ASD) are viable
strategies to enhance the release of poorly soluble drugs. The concurrency of the drug and …

Review of industrially recognized polymers and manufacturing processes for amorphous solid dispersion based formulations

SK Saha, A Joshi, R Singh, K Dubey - Pharmaceutical …, 2023 - Taylor & Francis
Evolving therapeutic landscape through combinatorial chemistry and high throughput
screening have resulted in an increased number of poorly soluble drugs. Drug delivery …

Predicting residence time and melt temperature in pharmaceutical hot melt extrusion

J Winck, T Gottschalk, M Thommes - Pharmaceutics, 2023 - mdpi.com
Hot-melt extrusion is increasingly applied in the pharmaceutical area as a continuous
processing technology, used to design custom products by co-processing drugs together …

[HTML][HTML] Trends in amorphous solid dispersion drug products approved by the US Food and Drug Administration between 2012 and 2023

DE Moseson, TB Tran, B Karunakaran… - International Journal of …, 2024 - Elsevier
Abstract Forty-eight (48) drug products (DPs) containing amorphous solid dispersions
(ASDs) have been approved by the US Food and Drug Administration in the 12-year period …

Self-nanomicellizing solid dispersion: A promising platform for oral drug delivery

W Chen, A Yan, T Sun, X Wang, W Sun… - Colloids and Surfaces B …, 2024 - Elsevier
Amorphous solid dispersion (ASD) has been widely used to enhance the oral bioavailability
of water-insoluble drugs for oral delivery because of its advantages of enhancing solubility …

Nano-Dry-Melting: A novel technology for manufacturing of pharmaceutical amorphous solid dispersions

M Hermeling, C Nueboldt, R Heumann, W Hoheisel… - Pharmaceutics, 2022 - mdpi.com
Amorphous solid dispersions (ASD) are one of the most prominent formulation approaches
to overcome bioavailability issues that are often presented by new poorly soluble drug …

Multivariate Analysis of Solubility Parameters for Drug-Polymer Miscibility Assessment in Preparing Raloxifene Hydrochloride Amorphous Solid Dispersions

GG Moreira, SF Taveira, FT Martins, KG Wagner… - AAPS …, 2024 - Springer
The success of obtaining solid dispersions for solubility improvement invariably depends on
the miscibility of the drug and polymeric carriers. This study aimed to categorize and select …